Goat IgG anti-Human Kappa light chain-unconj., MinX none

Artikelnummer: DNA-SEC-183008
Artikelname: Goat IgG anti-Human Kappa light chain-unconj., MinX none
Artikelnummer: DNA-SEC-183008
Hersteller Artikelnummer: SEC-183008
Alternativnummer: DNA-SEC-183008
Hersteller: dianova
Wirt: Goat
Kategorie: Antikörper
Applikation: ELISA,IHC,WB
Spezies Reaktivität: Human
Immunogen: Human kappa light chain
Konjugation: Unconjugated
Alternative Synonym: Goat Anti-Human kappa (kappa chain) Antibody, Goat Anti-Human kappa chain Antibody
Format: IgG
Spezifität: Kappa (light chain)
Minimale Kreuzreaktivität (MinX): no cross-adsorbtion
The anti-Human kappa (kappa chain) Antibody detects the kappa chain subunit. Immunoglobulins are heterotetramers composed of 2 immunoglobulin heavy and 2 immunoglobulin light chains. The immunoglobulin light chain is the small polypeptide subunit of an antib
Klonalität: Polyclonal
Konzentration: 1.0 mg/mL
Isotyp: Ig
Puffer: 0.125 M Sodium Borate, 0.075 M Sodium Chloride, 0.005 M EDTA, pH 8.0
Reinheit: Human κ (kappa chain) Antibody was prepared from monospecific antiserum by immunoaffinity chromatography using antigens coupled to agarose beads followed by solid phase adsorption(s) to remove any unwanted reactivities.   Assay by immunoelectrophoresis resulted in a single precipitin arc against anti-Goat Serum. Specificity for kappa chain was confirmed by ELISA minimal cross reactivity against other human heavy or lambda light chain isotypes.
Formulierung: Liquid (sterile filtered)
Formel: 125 mM Sodium Borate,75 mM NaCl,5 mM EDTA,pH 8,0,sterile filtered,0,01% NaN3
Target-Kategorie: Human
Antibody Type: Secondary Antibody
Application Verdünnung: ELISA Dilution: 1:10,000 - 1:20,000, Immunohistochemistry Dilution: 1:500 - 1:2,000, Western Blot Dilution: 1:1,000 - 1:10,000
Anwendungsbeschreibung: Human κ (kappa chain) Antibody is suitable for immunoassays where specificity to the immunoglobulin kappa subunit is desired. Antibody has been tested by ELISA, western blot immunoblot, and immunohistochemistry. Optimal concentrations in immunoassays should be determined by the researcher.